Functionally, MM cells interfere with physiologic bone remodeling by releasing OC-promoting cytokines such as receptor activator of NF-kappa B ligand (RANKL), interleukin (IL)-1, IL-6, chemokine C–C motif ligand 3 (CCL3), and CCL20. This evidence concerns the gene CCL20 and Miyoshi myopathy.